TSHA Operating Cash Flow (Statement)
Taysha Gene Therapies Inc · Operating Cash Flow (Statement)
TSHA Operating Cash Flow (Statement)
Latest reported-$40.43Mperiod ending
TSHA Quarterly Cash from Operations ($0.00 → -$40.43M)
Quarterly operating cash flow (statement)
High-resolution chart · PNG
TSHA operating cash flow (statement) history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -40,425,000 | |
| -40,878,000 | |
| -26,722,000 | |
| -24,166,000 | |
| -20,182,000 | |
| -22,020,000 | |
| -18,308,000 | |
| -21,615,000 | |
| -21,504,000 | |
| -19,798,000 | |
| -16,117,000 | |
| -17,949,000 | |
| -18,767,000 | |
| -20,185,000 | |
| 14,277,000 | |
| -28,810,000 | |
| -33,353,000 | |
| -40,939,000 | |
| -40,258,000 | |
| -31,933,000 | |
| -22,816,000 | |
| -22,035,000 | |
| -19,848,000 | |
| -6,716,000 | |
| -2,466,000 | |
| -1,699,000 | |
| 0 |